Back to Search
Start Over
[Anxiety associated with substance abuse].
- Source :
-
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2016; Vol. 116 (11. Vyp. 2), pp. 3-8. - Publication Year :
- 2016
-
Abstract
- Substance abuse and anxiety is a common comorbid dyad and an example of so-called dual diagnosis in psychiatry. Comorbidity of anxiety and addictive disorders may be due to interdependence of these states as well as common predisposing factors and pathogenic mechanisms. There are various medicines in the treatment of anxiety associated with substance abuse, including benzodiazepines, calcium channel modulators, non-benzodiazepine anxiolytics, antidepressants and antipsychotics. One of the best approaches to the treatment of chronic anxiety disorders in drug treatment clinic is a long course of treatment with antidepressants, primarily with selective serotonin reuptake inhibitors as first line preparations. Such medications as pregabalin, buspirone, etifoxine and alimemazine are also of interest for the treatment of dual diagnosis patients.
- Subjects :
- Antidepressive Agents therapeutic use
Antipsychotic Agents therapeutic use
Anxiety Disorders drug therapy
Benzodiazepines therapeutic use
Buspirone therapeutic use
Comorbidity
Humans
Selective Serotonin Reuptake Inhibitors therapeutic use
Substance-Related Disorders psychology
Anti-Anxiety Agents therapeutic use
Anxiety Disorders complications
Substance-Related Disorders complications
Subjects
Details
- Language :
- Russian
- ISSN :
- 1997-7298
- Volume :
- 116
- Issue :
- 11. Vyp. 2
- Database :
- MEDLINE
- Journal :
- Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
- Publication Type :
- Academic Journal
- Accession number :
- 28300806
- Full Text :
- https://doi.org/10.17116/jnevro20161161123-8